Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
24.22 USD | +1.36% | -0.58% | +213.50% |
Apr. 08 | Canaccord Genuity Adjusts Price Target on CervoMed to $65 From $50, Maintains Buy Rating | MT |
Mar. 29 | CervoMed Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Business Summary
Number of employees: 8
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Neurological Treatment
100.0
%
| - | - | 7 | 100.0 % | - |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 0 | nan % | 7 | 100.0 % | - |
Managers
Managers | Title | Age | Since |
---|---|---|---|
John Alam
CEO | Chief Executive Officer | 62 | 23-08-15 |
William Tanner
DFI | Director of Finance/CFO | 66 | 23-08-15 |
Kelly Blackburn
CTO | Chief Tech/Sci/R&D Officer | 60 | 23-08-15 |
Robert Cobuzzi
COO | Chief Operating Officer | 60 | 23-08-15 |
William Elder
LAW | General Counsel | 41 | 23-08-15 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Joshua Boger
CHM | Chairman | 72 | Feb. 06 |
John Alam
CEO | Chief Executive Officer | 62 | 23-08-15 |
Frank Zavrl
BRD | Director/Board Member | 58 | 23-08-15 |
Sylvie Grégoire
BRD | Director/Board Member | 63 | 23-08-15 |
Director/Board Member | 66 | 23-08-15 | |
Robert Cobuzzi
COO | Chief Operating Officer | 60 | 23-08-15 |
Jeffrey Poulton
BRD | Director/Board Member | 56 | 23-08-15 |
Director/Board Member | 58 | 23-08-15 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 8,253,741 | 5,369,547 ( 65.06 %) | 0 | 65.06 % |
Company contact information
Sector
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+213.24% | 197M | |
+2.97% | 108B | |
+10.21% | 104B | |
+1.57% | 22.33B | |
-12.77% | 22.19B | |
-7.05% | 18.69B | |
-37.64% | 17.74B | |
-6.50% | 17.64B | |
+6.00% | 14.05B | |
+37.20% | 12.51B |
- Stock Market
- Equities
- CRVO Stock
- Company CervoMed Inc.